MSPTX
Price
$15.04
Change
-$0.49 (-3.16%)
Updated
Feb 21 closing price
Net Assets
67.93M
RNPHX
Price
$64.29
Change
-$0.79 (-1.21%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

MSPTX vs RNPHX

Header iconMSPTX vs RNPHX Comparison
Open Charts MSPTX vs RNPHXBanner chart's image
Morgan Stanley Inst Global Insgt C
Price$15.04
Change-$0.49 (-3.16%)
VolumeN/A
Net Assets67.93M
American Funds New Perspective R5E
Price$64.29
Change-$0.79 (-1.21%)
VolumeN/A
Net Assets147.51B
MSPTX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSPTX vs. RNPHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSPTX is a Hold and RNPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 148B vs. MSPTX (67.9M). RNPHX pays higher dividends than MSPTX: RNPHX (1.00) vs MSPTX (0.00). MSPTX was incepted earlier than RNPHX: MSPTX (10 years) vs RNPHX (9 years). MSPTX is a more actively managed with annual turnover of: 43.00 vs. RNPHX (17.00). RNPHX has a lower initial minimum investment than MSPTX: RNPHX (250) vs MSPTX (1000). MSPTX annual gain was more profitable for investors over the last year : 53.45 vs. RNPHX (10.58). RNPHX return over 5 years is better than : 34.72 vs. MSPTX (-16.22).
MSPTXRNPHXMSPTX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years9 years-
Gain YTD7.3524.639158%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets67.9M148B0%
Annual Yield % from dividends0.001.00-
Returns for 1 year53.4510.58505%
Returns for 3 years38.8114.84262%
Returns for 5 years-16.2234.72-47%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO7.960.08
+1.02%
Gogo
PUK17.99-0.18
-0.99%
Prudential PLC
ABTS0.41-0.01
-2.14%
Abits Group
RARE42.59-1.89
-4.25%
Ultragenyx Pharmaceutical
SMID34.74-2.37
-6.39%
Smith-Midland Corp